SEC Tracker
Get the app

Revolution Medicines RVMD

Mark A Goldsmith (Officer) plans to sell 13,261 RVMD shares, about $1.3M

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Mar 16, 2026
  2. Broker: ETRADE Financial Corporation
  3. Shares acquired by: Restricted stock unit grant
  4. 10b5-1 plan adopted: May 31, 2023

All of Mark A Goldsmith's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 12,871 shares at $99.48 on Mar 17, 2026 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Revolution Medicines files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Repligen RGEN public float $6.0B, Jun 30, 2025
  2. Halozyme Therapeutics HALO public float $4.5B, Jun 30, 2025
  3. BIO-TECHNE TECH public float $9.1B, Dec 31, 2025
  4. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  5. CRISPR Therapeutics CRSP public float $4.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.